Ashland reports financial results1 for second quarter fiscal 2024 ; issues outlook for third quarter and full - year fiscal 2024

Ashland Inc. has reported a drop in sales in the second quarter of the year, according to its latest financial results. The company says revenue from continuing operations fell to $126 million, or $2.43 per diluted share, and income from discontinued operations remained higher than previously forecasted by the previous year s growth expectations.. () US manufacturing giant has said the annual earnings of $127m (123m) fell by 15% in third quarter, as demand continues to increase in both the personal care and specialty ingredients market. Financial results revealed sales of 5% of its products during the first three months of this year - which ended March 31, 2024, but is expected to be lower than the initial quarterly figures for the next three and full-year quarters, with sales falling sharply, despite rising demand for additional products and products, not seen as weaker than initially predicted, down by more than 2% in three years, after sales continued to fall in April, 2020, instead of profits from the last three consecutive weeks of sales and sales, at the end of March, 2021 and will continue to rise, thanks to the decline in production and production of pharmaceuticals and personal Care and Specialty Additives (S&P) markets across the world. As analysts report their outlook for next year and the full year of 2021, the company has seen another significant rise in demand and its profitability, sales have fallen.

Source: marketscreener.com
Published on 2024-04-30